Epigenic Therapeutics: Funding, Investors & Team (Sep 2026)
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.
Epigenic Therapeutics has raised $60.0M across 1 funding round on record, the most recent a Series B of $60.0M announced in Sep 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Epigenic Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Epigenic Therapeutics Funding Rounds
Epigenic Therapeutics Founders and Leadership Team
Contact details for the Epigenic Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Epigenic Therapeutics Funding Compared to Other Biotechnology Startups
Epigenic Therapeutics' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Epigenic Therapeutics in Biotechnology and Shanghai
Companies Similar to Epigenic Therapeutics
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
NewLine researches phage feed additives to prevent livestock infections.
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Epigenic Therapeutics Funding FAQs
What does Epigenic Therapeutics do?
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.
How much funding has Epigenic Therapeutics raised?
Epigenic Therapeutics has raised $60.0M across 1 round on record. The most recent is a Series B of $60.0M announced in Sep 2025.
When did Epigenic Therapeutics last raise funding?
Epigenic Therapeutics' most recent funding round on record is a Series B of $60.0M, announced in Sep 2025.
Where is Epigenic Therapeutics headquartered?
Epigenic Therapeutics is based in Shanghai, China.
How many employees does Epigenic Therapeutics have?
Epigenic Therapeutics is in the 101-250 employee band.
How does Epigenic Therapeutics' funding compare to other Biotechnology startups?
Epigenic Therapeutics' latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Epigenic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epigenic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.